{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:04:47Z","timestamp":1774875887136,"version":"3.50.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The kappa-opioid receptor (KOR) \/ dynorphin system is implicated with behavioral and neurobiological effects of stress exposure (including heavy exposure to drugs of abuse) in translational animal models. Thus some KOR-antagonists can decrease the aversive, depressant-like and anxiety-like effects caused by stress exposure. The first generation of selective KOR-antagonists have slow onsets (hours) and extremely long durations of action (days-weeks), <jats:italic>in vivo<\/jats:italic>. A new generation of KOR antagonists with rapid onset and shorter duration of action can potentially decrease the effects of stress exposure in translational models, and may be of interest for medication development. This study examined the rapid onset anti-stress effects of one of the shorter acting novel KOR-antagonists (LY2795050, (3-chloro-4-(4-(((2S)-2-pyridin-3-ylpyrrolidin-1-yl)methyl) phenoxy)benzamide)) in a single-session open space swim (OSS) stress paradigm (15\u00a0min duration), in adult male and female C57BL\/6\u00a0J mice. LY2795050 (0.32\u00a0mg\/kg, i.p.) had rapid onset (within 15\u00a0min) and short duration (&amp;lt;3\u00a0h) of KOR-antagonist effects, based on its blockade of the locomotor depressant effects of the KOR-agonist U50,488 (10\u00a0mg\/kg). LY2795050 (0.32\u00a0mg\/kg), when administered only 1\u00a0min prior to the OSS stress paradigm, decreased immobility in males, but not females. With a slightly longer pretreatment time (15\u00a0min), this dose of LY2795050 decreased immobility in both males and females. A 10-fold smaller dose of LY2795050 (0.032\u00a0mg\/kg) was inactive in the OSS, showing dose-dependence of this anti-stress effect. Overall, these studies show that a novel KOR-antagonist can produce very rapid onset anti-immobility effects in this model of acute stress exposure.<\/jats:p>","DOI":"10.3389\/fphar.2021.775317","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T06:42:15Z","timestamp":1637563335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Rapid-Onset Anti-Stress Effects of a Kappa-Opioid Receptor Antagonist, LY2795050, Against Immobility in an Open Space Swim Paradigm in Male and Female Mice"],"prefix":"10.3389","volume":"12","author":[{"given":"Caroline","family":"Baynard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Prisinzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo R.","family":"Butelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18396","DOI":"10.1073\/pnas.0910180106","article-title":"Zyklophin, A Systemically Active Selective Kappa Opioid Receptor Peptide Antagonist with Short Duration of Action","volume":"106","author":"Aldrich","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neubiorev.2021.06.014","article-title":"The Forced Swim Test: Historical, Conceptual and Methodological Considerations and its Relationship with Individual Behavioral Traits","volume":"128","author":"Armario","year":"2021","journal-title":"Neurosci. Biobehavioral Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41386-018-0125-6","article-title":"Sex Differences in Neural Mechanisms Mediating Reward and Addiction","volume":"44","author":"Becker","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/diagnostics11010123","article-title":"Animal Models of Depression: What Can They Teach Us about the Human Disease","volume":"11","author":"Becker","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF02245071","article-title":"Differential Effects of Systemically Administered Nor-Binaltorphimine (Nor-BNI) on Kappa-Opioid Agonists in the Mouse Writhing Assay","volume":"115","author":"Broadbear","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/0269881121996883","article-title":"Profile of a Short-Acting \u03ba-antagonist, LY2795050, on Self-Grooming Behaviors, Forced Swim Test and Locomotor Activity: Sex Comparison in Mice","volume":"35","author":"Butelman","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"B7","first-page":"595","article-title":"Kappa-Opioid Receptor Binding Populations in Rhesus Monkey Brain: Relationship to an Assay of thermal Antinociception","volume":"285","author":"Butelman","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.119.256354","article-title":"Impact of Pharmacological Manipulation of the \u03ba-Opioid Receptor System on Self-Grooming and Anhedonic-like Behaviors in Male Mice","volume":"370","author":"Butelman","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like Effects of the Kappa-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1021\/jm301783x","article-title":"Development of \u03ba Opioid Receptor Antagonists","volume":"56","author":"Carroll","year":"2013","journal-title":"J. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00213-020-05486-z","article-title":"Long-term Impact of Acute Restraint Stress on Heroin Self-Administration, Reinstatement, and Stress Reactivity","volume":"237","author":"Carter","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"Unit 8 10A","DOI":"10.1002\/0471142301.ns0810as55","article-title":"Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice","volume":"8","author":"Castagn\u00e9","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejphar.2009.06.018","article-title":"Use of Latency to Immobility Improves Detection of Antidepressant-like Activity in the Behavioral Despair Test in the Mouse","volume":"616","author":"Castagn\u00e9","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.neuropharm.2013.01.023","article-title":"Effects of Lurasidone in Behavioral Models of Depression. Role of the 5-HT\u2087 Receptor Subtype","volume":"70","author":"Cates","year":"2013","journal-title":"Neuropharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1208\/s12248-011-9296-3","article-title":"Quantitative PK-PD Model-Based Translational Pharmacology of a Novel Kappa Opioid Receptor Antagonist between Rats and Humans","volume":"13","author":"Chang","year":"2011","journal-title":"AAPS J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fnins.2015.00466","article-title":"Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction","volume":"9","author":"Chartoff","year":"2015","journal-title":"Front. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41386-018-0046-4","article-title":"Kappa-opioid Antagonists as Stress Resilience Medications for the Treatment of Alcohol Use Disorders","volume":"43","author":"Chavkin","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1038\/tp.2015.44","article-title":"Novel Insights into the Behavioral Analysis of Mice Subjected to the Forced-Swim Test","volume":"5","author":"Chen","year":"2015","journal-title":"Transl Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0376-8716(00)00209-x","article-title":"Sex Differences in Opioid Antinociception: Kappa and 'mixed Action' Agonists","volume":"63","author":"Craft","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"B20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.biopsych.2019.05.021","article-title":"The Kappa Opioid Receptor Is Associated with Naltrexone-Induced Reduction of Drinking and Craving","volume":"86","author":"De Laat","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1038\/s41386-019-0458-9","article-title":"Experimental Design and Analysis for Consideration of Sex as a Biological Variable","volume":"44","author":"Diester","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00213-014-3723-y","article-title":"Effects of Buprenorphine on Behavioral Tests for Antidepressant and Anxiolytic Drugs in Mice","volume":"232","author":"Falcon","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1021\/acs.jmedchem.8b01679","article-title":"Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140)","volume":"62","author":"Guerrero","year":"2019","journal-title":"J. Med. Chem."},{"key":"B24","first-page":"1237","article-title":"Extremely Long-Lasting Antagonistic Actions of Nor-Binaltorphimine (Nor-BNI) in the Mouse Tail-Flick Test","volume":"260","author":"Horan","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2016.03.061","article-title":"Synergistic Antidepressant-like Effects between a Kappa Opioid Antagonist (LY2444296) and a delta Opioid Agonist (ADL5859) in the Mouse Forced Swim Test","volume":"781","author":"Huang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev-pharmtox-010919-023317","article-title":"Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders","volume":"60","author":"Jacobson","year":"","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1007\/s00213-020-05649-y","article-title":"The Kappa Opioid Receptor Antagonist Aticaprant Reverses Behavioral Effects from Unpredictable Chronic Mild Stress in Male Mice","volume":"237","author":"Jacobson","year":"","journal-title":"Psychopharmacology (Berl)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"108254","DOI":"10.1016\/j.neuropharm.2020.108254","article-title":"Sex Differences in the Modulation of Mouse Nest Building Behavior by Kappa Opioid Receptor Signaling","volume":"177","author":"Jacobson","year":"","journal-title":"Neuropharmacology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","article-title":"Dynorphin, Stress, and Depression","volume":"1314","author":"Knoll","year":"2010","journal-title":"Brain Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fphar.2018.00093","article-title":"Sex Differences in the Effects of a Kappa Opioid Receptor Antagonist in the Forced Swim Test","volume":"9","author":"Laman-Maharg","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"19168","DOI":"10.1073\/pnas.0910705106","article-title":"Activation of the Kappa Opioid Receptor in the Dorsal Raphe Nucleus Mediates the Aversive Effects of Stress and Reinstates Drug Seeking","volume":"106","author":"Land","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11920-018-0983-y","article-title":"A Review of the Neurobiological Basis of Trauma-Related Dissociation and its Relation to Cannabinoid- and Opioid-Mediated Stress Response: a Transdiagnostic, Translational Approach","volume":"20","author":"Lanius","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1017\/S1461145710001161","article-title":"Further Evidence for an Immediate Antidepressant Action of Intracerebral Drug Administration in a Model of Chronic Depression","volume":"14","author":"Lin","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/jcph.286","article-title":"Safety, Tolerability, and Pharmacokinetic Evaluation of Single- and Multiple-Ascending Doses of a Novel Kappa Opioid Receptor Antagonist LY2456302 and Drug Interaction with Ethanol in Healthy Subjects","volume":"54","author":"Lowe","year":"2014","journal-title":"J. Clin. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0232864","DOI":"10.1371\/journal.pone.0232864","article-title":"Differential Effects of Novel Kappa Opioid Receptor Antagonists on Dopamine Neurons Using Acute Brain Slice Electrophysiology","volume":"15","author":"Margolis","year":"2020","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1124\/mol.111.074195","article-title":"Duration of Action of a Broad Range of Selective \u03ba-opioid Receptor Antagonists Is Positively Correlated with C-Jun N-Terminal Kinase-1 Activation","volume":"80","author":"Melief","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2019.02.005","article-title":"Coping with the Forced Swim Stressor: Current State-Of-The-Art","volume":"364","author":"Molendijk","year":"2019","journal-title":"Behav. Brain Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2967\/jnumed.114.147975","article-title":"Test-retest Reproducibility of Binding Parameters in Humans with 11C-LY2795050, an Antagonist PET Radiotracer for the \u03ba Opioid Receptor","volume":"56","author":"Naganawa","year":"2015","journal-title":"J. Nucl. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/ijnp\/pyz054","article-title":"Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats","volume":"22","author":"Page","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"007","DOI":"10.4172\/2155-6105.s4174-400710.4172\/2155-6105.S4-007","article-title":"Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment","author":"Paris","year":"2011","journal-title":"J. Addict. Res. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1021\/acschemneuro.8b00293","article-title":"Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging","volume":"10","author":"Placzek","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\"Behavioural Despair\" in Rats and Mice: Strain Differences and the Effects of Imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"B43","first-page":"327","article-title":"Behavioral Despair in Mice: a Primary Screening Test for Antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","article-title":"Binaltorphimine and Nor-Binaltorphimine, Potent and Selective Kappa-Opioid Receptor Antagonists","volume":"40","author":"Portoghese","year":"1987","journal-title":"Life Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/npp.2017.205","article-title":"Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-R Antagonist, in Persons with and without Cocaine Dependence","volume":"43","author":"Reed","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neuroscience.2012.06.006","article-title":"Chromatin Alterations in Response to Forced Swimming Underlie Increased Prodynorphin Transcription","volume":"220","author":"Reed","year":"2012","journal-title":"Neuroscience"},{"key":"B47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","article-title":"LY2456302 Is a Novel, Potent, Orally-Bioavailable Small Molecule Kappa-Selective Antagonist with Activity in Animal Models Predictive of Efficacy in Mood and Addictive Disorders","volume":"77","author":"Rorick-Kehn","year":"2014","journal-title":"Neuropharmacology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"8991","DOI":"10.1007\/s12035-018-1024-x","article-title":"m-Trifluoromethyl-diphenyl Diselenide Regulates Prefrontal Cortical MOR and KOR Protein Levels and Abolishes the Phenotype Induced by Repeated Forced Swim Stress in Mice","volume":"55","author":"Rosa","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress Increases Dynorphin Immunoreactivity in Limbic Brain Regions and Dynorphin Antagonism Produces Antidepressant-like Effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J. Neurochem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.pbb.2008.07.006","article-title":"Evaluation of the Repeated Open-Space Swim Model of Depression in the Mouse","volume":"91","author":"Stone","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s00213-017-4647-0","article-title":"\"Effects of the Novel Relatively Short-Acting Kappa Opioid Receptor Antagonist LY2444296 in Behaviors Observed after Chronic Extended-Access Cocaine Self-Administration in Rats\"","volume":"234","author":"Valenza","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00213-019-05444-4","article-title":"Effects of Kappa Opioid Receptor Blockade by LY2444296 HCl, a Selective Short-Acting Antagonist, during Chronic Extended Access Cocaine Self-Administration and Re-exposure in Rat","volume":"237","author":"Valenza","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"109812","DOI":"10.1016\/j.pnpbp.2019.109812","article-title":"Adolescent Forced Swim Stress Increases Social Anxiety-like Behaviors and Alters Kappa Opioid Receptor Function in the Basolateral Amygdala of Male Rats","volume":"98","author":"Varlinskaya","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pnpbp.2018.06.001","article-title":"Acute Inhibition of Kappa Opioid Receptors before Stress Blocks Depression-like Behaviors in California Mice","volume":"86","author":"Williams","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejphar.2007.05.045","article-title":"Central Kappa-Opioid Receptor-Mediated Antidepressant-like Effects of Nor-Binaltorphimine: Behavioral and BDNF mRNA Expression Studies","volume":"570","author":"Zhang","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2967\/jnumed.112.109512","article-title":"Synthesis and Evaluation of 11C-LY2795050 as a \u03ba-opioid Receptor Antagonist Radiotracer for PET Imaging","volume":"54","author":"Zheng","year":"2013","journal-title":"J. Nucl. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.775317\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T06:42:19Z","timestamp":1637563339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.775317\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":56,"alternative-id":["10.3389\/fphar.2021.775317"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.775317","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"article-number":"775317"}}